Partillion Bioscience Expands Nanovial Technology at CYTO 2026 Conference

Advancements in Cell Interaction Analysis: Partillion Bioscience at CYTO 2026

Introduction

From June 6 to 10, 2026, the CYTO conference in West Palm Beach, Florida, served as a stage for groundbreaking innovations in cellular analysis. Among the prominent exhibitors, Partillion Bioscience drew significant attention with its latest developments in its Nanovial technology—an innovative platform that enhances the understanding of cell-cell interactions, which are essential for various biological processes and therapeutic responses.

The Importance of Cell Interactions

Cellular interactions are the foundational processes driving immune responses, tumor behavior, and overall health. Traditional single-cell technologies primarily analyze cells in isolation, which may overlook critical interactions that can influence cellular behavior and therapeutic outcomes. This challenge is precisely what Partillion's Nanovial technology aims to address, offering new tools that facilitate a more integrative approach to cellular analysis.

Highlights of Nanovial Implementations at CYTO 2026

At the conference, Partillion showcased a series of five scientific talks detailing innovative applications of Nanovial workflows. These presentations covered significant areas such as:

1. Immune-Tumor Interactions: The effectiveness of therapies often hinges on understanding how immune cells interact with tumor cells. Nanovials enable detailed insights into these complex behaviors, ultimately aiding in refining treatment strategies.
2. Antibody Discovery: The platform supports researchers in identifying and developing new antibodies, providing critical data on how cells interact during the discovery phases.
3. Large-Particle Cytometry: With the integration of Nanovials into flow cytometry and sorting workflows, there is potential for high-throughput analysis that was challenging to achieve before.
4. Functional Screening: The ability to capture and connect cellular functions with identity provides a new avenue for functional genomics.

In conjunction with these presentations, Partillion also published a preprint entitled "Cell-Cell-Seq Resolves Contact-Associated NK Cell Activation in Defined Tumor Cell Dyads." This work demonstrates that Nanovial technologies can generate interaction-resolved datasets, offering clarity on early NK cell activation programs that traditional co-culture methods may hide.

A Testament to Innovation

Partillion's co-founder, Dr. Dino Di Carlo, also delivered the Tech Pioneer Lecture at CYTO 2026. He emphasized the transformative potential of Nanovials, explaining how they empower researchers to dismantle disease-driven cellular interactions. This capability could lead to novel therapeutic strategies, representing a paradigm shift in the treatment landscape.

Dr. Jingjing Zhao from Huazhong University of Science and Technology lauded Partillion’s technology, stating, "Partillion's Nanovial technology is an exciting example of how new tools can broaden the applications of cytometry. By enabling researchers to study secreted signals and other functional readouts using existing workflows, this work helps bring more complex biological questions into reach."

Future Implications

The presence of Nanovial technology at CYTO 2026 is a promising sign for the future of cytometric analysis. The platform not only augments the existing research framework but also opens pathways to understanding complex biological interactions. As researchers continue to explore the implications of these findings, the potential for advancements in immunotherapy, cancer research, and cellular biology is tremendous.

About Partillion Bioscience

Partillion Bioscience is at the forefront of functional cell analysis, driven by its award-winning Nanovial technology. The company's mission is to facilitate and speed up the development of therapies by enabling research partners to screen millions of live cells efficiently. The power of Nanovial technology lies not only in capturing functional outputs of cells—such as signaling and secretion—but also in its adaptability to current research infrastructures.

As the life sciences landscape evolves, Partillion aims to remain a key player, pushing the boundaries of what is possible in cellular interaction analysis. For more information about their innovative technologies, visit Partillion's website.